                         SEQUENCE LISTING

<110>  The University of North Carolina at Chapel Hill
       Kibbe, Melina
       Marulanda, Kathleen
       Mercel, Alexandra
       Tsihlis, Nick
 
<120>  NANOMATERIALS FOR TARGETED TREATMENT OF PULMONARY TISSUE

<130>  035052/553420

<150>  62/968,919
<151>  2020-01-31

<160>  19    

<170>  PatentIn version 3.5

<210>  1
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  1

Leu Val Phe Phe Ala Glu Asp 
1               5           


<210>  2
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  2

Ala Met Val Thr Thr Ala Cys His Glu Phe Phe Glu His 
1               5                   10              


<210>  3
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  3

Lys Gly Val Val Lys Ala Glu Lys Ser Lys 
1               5                   10  


<210>  4
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  4

Val Val Ala Ala Glu Glu 
1               5       


<210>  5
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  5

Glu Glu Ala Ala Val Val Lys 
1               5           


<210>  6
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  6

Arg Tyr Asp Phe 
1               


<210>  7
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  7

Thr Pro Thr Gln Gln 
1               5   


<210>  8
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  8

Gly Asn Gly Ser Gly Tyr Val Ser Arg 
1               5                   


<210>  9
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  9

Ala Met Val Thr Thr Ala Ala His Glu Phe Phe Glu His 
1               5                   10              


<210>  10
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  10

Val Val Ala Ala Glu Glu Gly Gly Lys Gly Val Val Lys Ala Glu Lys 
1               5                   10                  15      


Ser Lys 
        


<210>  11
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  11

Val Val Ala Ala Glu Glu Gly Gly Leu Val Phe Phe Ala Glu Asp 
1               5                   10                  15  


<210>  12
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  12

Val Val Ala Ala Glu Glu Gly Gly Arg Tyr Asp Phe 
1               5                   10          


<210>  13
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  13

Thr Pro Thr Gln Gln Gly Gly Glu Glu Ala Ala Val Val Lys 
1               5                   10                  


<210>  14
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  14

Thr Pro Thr Gln Gln Ser 
1               5       


<210>  15
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  15

Val Val Ala Ala Glu Glu Lys 
1               5           


<210>  16
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  16

Val Val Ala Ala Glu Glu Gly Gly Gly Asn Gly Ser Gly Tyr Val Ser 
1               5                   10                  15      


Arg 
    


<210>  17
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  17

Val Val Ala Ala Glu Glu Gly Gly Ala Met Val Thr Thr Ala Ala His 
1               5                   10                  15      


Glu Phe Phe Glu His 
            20      


<210>  18
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  18

Gln Thr Ser Val Ser Pro Ser Lys Val Ile 
1               5                   10  


<210>  19
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  19

Ile Thr Asp Gly Glu Ala Thr Asp Ser Gly 
1               5                   10  


